SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?


To: R. M. Rosenthal who wrote (583)12/11/1997 2:52:00 PM
From: Karl Drobnic  Read Replies (1) | Respond to of 5736
 
Since Skipard made me aware of CCSI several months ago, every mother I've talked to has been aware of bilirubin testing. I also talked to a senior engineer at a top-quality medical device company. His job is to think up new medical devices to sell to hospitals. He told me that one of the hottest things in the medical device world is to find non-invasive methods that replace blood tests. My conclusions are that any mother who can afford it wants her baby tested for bilirubin, and that CCSI has a hot trend in its favor. Those are two powerful forces when you're sifting through the small-cap, development stage investment scene.



To: R. M. Rosenthal who wrote (583)12/11/1997 3:53:00 PM
From: JanyBlueEyes  Read Replies (2) | Respond to of 5736
 
RMR

I put the Research Magazine article there because it was the most up to date consolidated information on the Company. I feel it should be there simply to give the entire scope of the company and it's potential in other markets besides medical.

I assume that if anyone had any specific questions regarding how many babies are monitored they would look for more information and go to the size of market news and find it there. Those numbers are backed up with references.

Being a mother of 3 myself, I most definitely remember the nurses talking about the bilirubin levels. I know that all 3 of my kids were monitored for the level of bilirubin in their blood. It was always a concern. From my own personal experience IMO all babies are monitored for increased levels of bilirubin.

From exchange2000.com

The World Health Organization has published the current annual birthrate of approximately 4,000,000 births in the United States, with approximately 10 percent of these births being premature infants. The company estimates that individual bilirubin blood tests on newborn infants (heelsticks) which are not part of a general panel blood test, total approximately 15,000,000 tests performed annually in the United States, based on data made available by the World Health Organization, the American Academy of Pediatrics, independent market studies commissioned by the company and business proposals from potential marketing partners.

Jane